A mechanism of TNFR type II (75 kDa) "shedding" in macrophages

Shock

Volumn 11, Issue 1, 1999, Pages 19-28

  Coyne, Cody P ^a,c   Willetto, Carla ^a,d   Fenwick, Brad W ^b  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c MISSISSIPPI STATE UNIVERSITY   (United States)

^d Ilisagvik College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; PROTEINASE; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL; ARTICLE; BLOOD; CATTLE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; FEMALE; ISOLATION AND PURIFICATION; LEUKOCYTE; MACROPHAGE; METABOLISM;

ANIMALS; ANTIGENS, CD; CATTLE; ENDOPEPTIDASES; FEMALE; LEUKOCYTES; MACROPHAGES; PROTEASE INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 0032622235     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199901000-00003     Document Type: Article

References (47)

1. Aiyer RA, Aggarwal BB: Characterization of receptors for recombinant human tumor necrosis factor-alpha from human placental membranes. Lymphokine Res 9:333-343, 1990.
2. Levine SJ, Logun C, Chopra DP: Protein kinase C, interleukin-1 beta, and corticosteroid regulated shedding of the type I, 55 kDa TNF-alpha receptor from human airway epithelium. Am J Respir Cell Mol Biol 14(3):254-261, 1996.
3. Ding AH, Porteu F, Sanchez E, Nathan CF: Down-regulation of tumor necrosis factor receptors on macrophages and endothelial cells by depolymerizing agents. J Exp Med 171:715-720, 1990.
4. Porteu F, Nathan C: Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 172:599-607, 1990.
5. Ohmann HB, Campos M, McDougall L, Lawman MJP, Babiuk LA: Expression of tumor necrosis factor-alpha receptors on bovine macrophages, lymphocytes and polymorphonuclear leukocytes, internalization of receptor-bound ligand, and some functional effects. Lymphokine Res 9:43-58, 1990.
6. Ding A H, Sanchez E, Scimal S: Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J Biol Chem 264:3924-3929, 1989.
7. Luettig B, Decker T, Lohmann-Matthes ML: Evidence for the existence of two forms of membrane tumor necrosis factor: An integral protein and a molecule attached to its receptor. J Immunol 143:4034-4038, 1989.
8. Owen-Schaub LB, Crump WL, Morin GI, Grimm EA: Regulation of lymphocyte tumor necrosis factor receptors by IL-2. J Immunol 143: 2236-2241, 1989.
9. Andrews JS, Berger AE, Ware CF: Characterization of the receptor for tumor necrosis factor (TNF), lymphotoxin (LT) on human T lymphocytes. J Biol Chem 264:11974-11980, 1989.
10. Lee SY, Park CG, Choi Y: T-cell receptor dependent cell death of T-cell hybrydomas mediated by the CD30 cytoplasmic domain is associated with tumor necrosis factor receptor-associated factors. J Exp Med 183(2):669-674, 1996.
11. Gedrich RW, Gilfillen MC, Duckett CS: CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor associated family of signal transducing proteins. J Biol Chem 271(22):12852-12858, 1996.
12. Hohmann HP, Remy R, Poschl B: Tumor necrosis factors-alpha and beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kB at low receptor occupancy and within minutes after receptor binding. J Biol Chem 265:15183-15188, 1990.
13. Stauber GB, Aggarwal BB: Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (Tumor Necrosis Factor-beta) on a human histiocytic lymphoma cell line, U937. J Biol Chem 264:3573-3576, 1989.
14. Seckinger P, Vey E, Turcatti G: Tumor necrosis factor inhibitor: purification, amino-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulating activities. Eur J Immunol 20:1167-1174, 1989.
15. Jones EY, Stuart DI, Walker NPC: Structure of tumor necrosis factor. Nature 338:225-228, 1989.
16. Joyce DA, Steer JH: Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p 75 receptors but not p55 TNF receptors from human monocytes. J Interferon Cytokine Res 15(11):947-954, 1995.
17. Dembic Z, Loetscher H, Gubler U: Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2:231-237, 1990.
18. Katsura K, Park M, Gatanaga M: Identification of the proteolytic enzyme which cleaves human p 75 receptor in-vivo. Biochem Biophys Res Commun 222(2):298-302, 1996.
19. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibody. Proc Natl Acad Sci 87:3127-3131, 1990.
20. Loetscher H, Schlaeger EJ, Lahm HW: Molecular cloning and expression of the human 55 kDa tumor necrosis factor receptor. Cell 61:351-359, 1990.
21. Porteu F, Brockaus M, Wallach D: Human neutrophil elastase release and ligand-binding fragment from the 75 kDa tumor necrosis factor (TNF) receptor. J Biol Chem 1266:18846-18853, 1991.
22. Engelmann H, Holtmann H, Brakebusch C: Antibodies to a soluble form of tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 265:14497-14504, 1990.
23. Hohmann HP, Brockhaus M, Baeuerle PA: Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated and both receptors mediate activity of the transcription factor NF-kappa B. TNF-alpha is not needed for induction of a biological effect via TNF receptors. J Biol Chem 265:22409-22417, 1990.
24. Hohmann HP, Remy R, Brockhaus M, van Loon APGM: Two different cell types have different major receptors for human necrosis factor (TNF-alpha). J Biol Chem 264:14927-14934, 1989.
25. Loetscher HR, Schlaeger EJ, Lahm HW: Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cell. J Biol Chem 265:20131-20139, 1990.
26. Tartaglia LA, Goeddle DV: Two TNF receptors. Immunol Today 13:151-158, 1992, 1992.
27. Coyne CP, Fenwick BW, Iandolo J, Griffith G, Williams D: Isolation of an inhibitor of TNF-alpha from activated equine mixed white blood cell populations. Am J Vet Res 54:845-855, 1993.
28. Corti A, Merli S, Bagnasco L: Identification of two forms (31-33, 48 kDa) of the urinary soluble p 55 tumor necrosis factor receptor that are differentially N- and O-glycosylated. J Interferon Cytokine Res 15(2):143-152, 1995.
29. Rochemonteix BGD, Nicod LP, Dayer JM: Tumor necrosis factor soluble j receptor 75: The principal receptor form released by human alveolar macrophages and monocytes in the presence of Interferon (gamma). Am J Resp Cell Mol Biol 14(3):279-287, 1996.
30. Lien E, Liabakk NB, Johnsen AC: Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Eur J Immunol 25(9):2714-2717, 1995.
31. Messer J, Eyer D, Danato L: Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 129(4):574-580, 1996.
32. Mullberg J, Durie FH, Otten-Evans C, Alderson MR: A metaloprotease inhibitor blocks shedding fo the IL-6 receptor and the p 60 TNF receptor. J Immunol 155:5198-5205, 1995.
33. van Kessel KP: Inactivation of recombinant human tumor necrosis factor alpha by proteolytic enzymes released from stimulated human neutrophils. J Immunol 147:3867-3868, 1991.
34. Gullberg U, Lantz M, Nilsson E: Characterization of a relationship between the T-lymphocyte derived differentiation inducing factor (DIF) and lymphotoxin: a common receptor system for DIF, lymphotoxin, and tumour necrosis factor downregulated by phorbol diesters. Eur J Haematol 39:241-250, 1987.
35. Politis I, Zhao X, McBride BW, Burton JH, Turner JD: Plasminogen activator production by bovine milk macrophages and blood monocytes. Am J Vet Res 58:1208-1213, 1991.
36. Adams JL, Czuprynski CJ: Bacterial lipopolysaccharide induces release of tumor necrosis factor-alpha from bovine peripheral blood monocytes, and alveolar macrophages in-vitro. J Leuk Biol 48:549-556, 1990.
37. Balazovich KJ, Suchard SJ, Remick DG: Tumor necrosis factor-alpha and fMLP receptors are functionally linked during fMLP-stimulated activation of adherent human neutrophils. Blood 88(2):690-696, 1996.
38. Pichyangkul S, Schick D, Jia FL: Binding of tumor necrosis factor (TNF-alpha) to high affinity receptors on polymorphonuclear cells. Exp Hematol 15:1055-1060, 1987.
39. Hwang CD: A 20 aminoacid synthetic peptide of a region from the 35 kDa human TNF receptor inhibits cytolytic, binding activities of recombinant human tumor necrosis factor in-vitro. Proc R Soc Lond Biol Sci 22(245)1313:115-119, 1991.
40. Engelman H, Aderka D, Rubinstein M: A tumour necrosis factor-binding protein purified to homogeneity protects cells from tumour necrosis factor toxicity. J Biol Chem 264:11974-11983, 1989.
41. Orlando S, Matteucci C, Fadlon EJ, Buurman WA: TNF-alpha, unlike other pro-and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J Immunol 158:3861-3868, 1997.
42. Brakebusch C, Nophar Y, Kemper O: Cytoplasmic truncation of the p 55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO 11:943-951, 1992.
43. Lantz M, Gullberg U, Nilsson E: Characterization in-vitro of a human tumour necrosis factor-binding protein. A soluble form of a tumour necrosis factor receptor. J Clin Invest 86:1396-1403, 1990.
44. Downing JR, Rousell MF, Sherr CJ: Ligand and protein kinase C down-modulate the colony stimulating factor I receptor by independent mechanisms. Mol Cell Biol 9:2890-2899, 1989.
45. Socher SH, Riemen MW, Martinez D, Friedman A: Competative inhibition of TNF-alpha receptor site binding. Proc Natl Acad Sci 84:8829-8833, 1987.
46. Jacobs GR, Pike RN, Dennison C: Isolation of cathepsin-D using three-phase partitioning in t-butanol/water/ammonium sulfate and pepstatin-A affinity chromatography. Anal Biochem 180:169-171, 1989.
47. Smith SK, Smith WD: Immunization of sheep with an integral membrane glucoprotein complex of Haemonchus contortus and with it's major polypeptide components. Res Vet Sci 60:1-6, 1996.